JERUSALEM, May 15, 2026 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), ("Scinai" or the "Company") a biopharmaceutical company focused on inflammation and immunology, today announced that members of its leadership team will lead a strategic roundtable discussion at the 7th...
Hence then, the article about scinai immunotherapeutics to lead strategic roundtable discussion on oral therapies and the future of biologics at the 7th dermatology drug development summit europe was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Scinai Immunotherapeutics to Lead Strategic Roundtable Discussion on Oral Therapies and the Future of Biologics at the 7th Dermatology Drug Development Summit Europe )
Also on site :
- 01F Group Announces Investment in DANA, Indonesia's Leading Digital Financial Company, Reinforcing Long-Term Confidence in Asia's Fintech Opportunity
- ‘A huge problem’: Trump has traded more stocks than all of Congress combined. A Bush-era ethics lawyer explains why you should worry
- William Shatner, 95, Walked Onstage With a Band Nobody Expected Him to Front; the ‘Star Trek’ Legend Covered Ozzy Osbourne and Metallica in Chicago